Anavex Life Sciences
AVXL
#8653
Rank
S$0.29 B
Marketcap
S$3.23
Share price
-2.16%
Change (1 day)
-77.37%
Change (1 year)

Anavex Life Sciences (AVXL) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : S$8.23 Million

According to Anavex Life Sciences 's latest financial reports the company's total liabilities are S$8.23 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Anavex Life Sciences - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-09-30S$11.54 M-41.31%
2024-09-30S$19.66 M14.86%
2023-09-30S$17.12 M16.79%
2022-09-30S$14.66 M-0.04%
2021-09-30S$14.66 M47.11%
2020-09-30S$9.96 M43.13%
2019-09-30S$6.96 M31.14%
2018-09-30S$5.31 M9.03%
2017-09-30S$4.87 M11.92%
2016-09-30S$4.35 M14.92%
2015-09-30S$3.78 M-58.54%
2014-09-30S$9.13 M154.82%
2013-09-30S$3.58 M1.01%
2012-09-30S$3.54 M103.12%
2011-09-30S$1.74 M-59.62%
2010-09-30S$4.32 M-28.34%
2009-09-30S$6.03 M82.78%
2008-09-30S$3.3 M383.87%
2007-09-30S$0.68 M1435.37%
2006-09-30S$0.04 M-2.53%
2005-09-30S$0.04 M983.75%
2004-09-30S$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ligand Pharmaceuticals
LGND
S$0.69 B 8,294.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
S$0.22 B 2,676.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S$3.4 M-58.66%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$1.31 B 15,892.62%๐Ÿ‡บ๐Ÿ‡ธ USA